We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Omega-3 wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
3 of 4 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
18 of 27 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Molybdenum and Omega-3 have evidence — compare verdict strength side-by-side.
50-150mcg daily
With or without food, Any time of day
Sodium Molybdate or Molybdenum Glycinate
2-3g combined EPA+DHA daily
With meals containing fat
Triglyceride form fish oil
1-2 weeks
2-4 weeks
4-8 weeks
2-4 weeks
Immediate
4-12 weeks
Change in Mineral Status After Bariatric Surgery: a Meta-analysis
Obesity surgery (2023) · Meta analysis · n=47432
The most severe mineral deficiency after bariatric surgery was iron (20.1%), followed by zinc (18.3%), copper (14.4%), chlorine (12.2%), phosphorus (7.5%), and calcium (7.4%).
A systematic review and meta-analysis of the hyperuricemia risk from certain metals
Clinical rheumatology (2022) · Meta analysis · n=63283
Data were pooled by random-effects models and expressed as pooled odds ratios (OR) and 95% confidence intervals (CIs).
Beyond the Mind-Serum Trace Element Levels in Schizophrenic Patients: A Systematic Review
International journal of molecular sciences (2020) · Systematic review
This review includes the analysis of serum levels of the following trace elements: iron, nickel, molybdenum, phosphorus, lead, chromium, antimony, uranium, magnesium, aluminum, zinc, copper, selenium, calcium, and manganese.
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
The New England journal of medicine (2019) · Rct · n=25871
During a median follow-up of 5.3 years, a major cardiovascular event occurred in 386 participants in the n-3 group and in 419 in the placebo group (hazard ratio, 0.92; 95% confidence interval [CI], 0.80 to 1.06; P=0.24).
Omega-3 fatty acids for intermittent claudication
The Cochrane database of systematic reviews (2024) · Meta analysis · n=1830
Omega-3 compared with a control may have little to no effect on ankle-brachial index (MD -0.02, 95% CI -0.08 to 0.04; 3 studies, 168 participants; very low-certainty evidence).
A systematic review and meta-analysis of the omega-3 fatty acids effects on brain-derived neurotrophic factor (BDNF)
Nutritional neuroscience (2024) · Meta analysis · n=587
The present systematic review and meta-analysis indicate the efficacy of omega-3 FAs in increasing the serum concentration of BDNF.
Limited direct RCT evidence. One controlled trial showed effects on metabolic parameters with molybdenum intervention. Conservative estimates given sparse human data and reliance on mechanism-based extrapolation from enzyme cofactor function.
Based on multiple meta-analyses showing EPA-dominant formulas >1g/day most effective. Effects plateau around 2-2.5g. Adjunctive use with antidepressants shows better outcomes than monotherapy.
AI-estimated from published studies. Interpret as directional guidance.
Omega-3 has a higher evidence score (9/10 vs 3.5/10) and wins in 2 of 3 categories.
For reduce inflammation, Omega-3 has a higher relevance score (90 vs 60).
No known interactions between Molybdenum and Omega-3 have been documented in our database. However, always consult a healthcare provider before combining supplements.